Akdamar Erol R bought HCA

February 16, 2024 · Form 4 insider transaction

Akdamar Erol R bought 7,700 shares of HCA Healthcare, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
7,700
Price
$0.00
Total value
N/A
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 16, 2024
Filing dateFebruary 21, 2024
Shares owned after7,700
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On February 3, 2021, the reporting person was granted 3,850 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

View the original Form 4 on SEC EDGAR
Akdamar Erol R bought HCA: February 16, 2024 | Insider Trading Screener